CRISPR Therapeutics proposes IPO

CRISPR Therapeutics AG, Basel, Switzerland Business: Gene/Cell therapy, Hematology, Pulmonary Date announced: 2016-09-09 Type: IPO To be raised: Up to $90 million Shares: TBD Price: TBD Underwriters: ...